Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Using convolutional neural network to predict remission of diabetes after gastric bypass surgery: a machine learning study from the Scandinavian Obesity Surgery Register

View ORCID ProfileYang Cao, View ORCID ProfileIngmar Näslund, View ORCID ProfileErik Näslund, View ORCID ProfileJohan Ottosson, View ORCID ProfileScott Montgomery, View ORCID ProfileErik Stenberg
doi: https://doi.org/10.1101/2020.11.03.20224956
Yang Cao
1Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro 70182, Sweden
2Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm 17177, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yang Cao
  • For correspondence: yang.cao@oru.se
Ingmar Näslund
3Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ingmar Näslund
Erik Näslund
4Division of Surgery, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erik Näslund
Johan Ottosson
3Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johan Ottosson
Scott Montgomery
1Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro 70182, Sweden
5Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Stockholm 17177, Sweden
6Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Scott Montgomery
Erik Stenberg
3Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erik Stenberg
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Prediction of diabetes remission is an important topic in the evaluation of patients with type-2 diabetes (T2D) before bariatric surgery. While several high-quality predictive indices are available, artificial intelligence (AI) algorithms offer the potential for higher predictive capability. The objective was to construct and validate an AI prediction model for diabetes remission after Roux-en-Y gastric bypass surgery.

Methods Patients who underwent surgery from 2007 until 2017 were included in the study, with collection of individual data from the Scandinavian Obesity Surgery Registry (SOReg), the Swedish National Patients Register, the Swedish Prescribed Drugs Register, and Statistics Sweden. A 7-layer convolution neural network (CNN) model was developed using 80% of patients randomly selected from SOReg and 20% of patients for external testing. The predictive capability of the CNN model and currently used scores (DiaRem, Ad-DiaRem, DiaBetter and IMS) were compared.

Results In total, 8057 patients with T2D were included in the study. At 2 years after surgery 77.1% achieved pharmacological remission, while 62.2% achieved complete remission. The area under the receiver operating curve (AUC) for the CNN-model for pharmacological remission was 0.85 [95% confidence interval (CI): 0.83-0.86] during validation, and 0.83 for the final test, which was 9-12% better than the traditional predictive indices. AUC for complete remission was 0.83 (95% CI: 0.81-0.85) during validation, and 0.82 for the final test, which was 9-11% better than the traditional predictive indices.

Conclusion The CNN method had better predictive capability compared to traditional indices for diabetes remission. However, further validation is needed in other countries to evaluate its external generalizability.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the regional ethics committee in Stockholm (reference numbers: 2013/535-31/5, 2014/1639-32, and 2017/857-32).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the study are not publicly available because they contain information that could compromise research participant privacy and confidentiality. The authors will make the data available upon reasonable request and with permission of the Committee of Scandinavian Obesity Surgery Registry in Orebro, Sweden.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 04, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Using convolutional neural network to predict remission of diabetes after gastric bypass surgery: a machine learning study from the Scandinavian Obesity Surgery Register
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Using convolutional neural network to predict remission of diabetes after gastric bypass surgery: a machine learning study from the Scandinavian Obesity Surgery Register
Yang Cao, Ingmar Näslund, Erik Näslund, Johan Ottosson, Scott Montgomery, Erik Stenberg
medRxiv 2020.11.03.20224956; doi: https://doi.org/10.1101/2020.11.03.20224956
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Using convolutional neural network to predict remission of diabetes after gastric bypass surgery: a machine learning study from the Scandinavian Obesity Surgery Register
Yang Cao, Ingmar Näslund, Erik Näslund, Johan Ottosson, Scott Montgomery, Erik Stenberg
medRxiv 2020.11.03.20224956; doi: https://doi.org/10.1101/2020.11.03.20224956

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (141)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4805)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (670)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (84)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5278)
  • Intensive Care and Critical Care Medicine (323)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (437)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (765)
  • Public and Global Health (1796)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)